Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 584 Projects
Project # Contact PI Funding Organization Fiscal Year
Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease
ADDF-54 Sninsky, John Alzheimer's Drug Discovery Foundation 2022
Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease: Clinical Validation, IVD Product Development, and Market Development
ADDF-55 Wilson, David Alzheimer's Drug Discovery Foundation 2022
Identifying a Patient-Specified Core Digital Measures Set in Alzheimer’s Disease and Related Dementias
ADDF-56 Goldsack, Jennifer Alzheimer's Drug Discovery Foundation 2022
Discovery of selective LRP1 inhibitors to prevent tau uptake and spread
ADDF-57 Kosik, Kenneth Alzheimer's Drug Discovery Foundation 2022
Repairing neurotransmission in Alzheimer's disease and related disorders by targeting caspase-2
ADDF-58 Ashe, Karen Alzheimer's Drug Discovery Foundation 2022
FINGERS Brain Health Institute
ADDF-59 Kivipelto, Miia Alzheimer's Drug Discovery Foundation 2022
Validation of the Retinal Deep Phenotyping (TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer's disease
ADDF-31 Sylvestre, Jean-Philippe Alzheimer's Drug Discovery Foundation 2021
Measurement of immune cell recruitment as a biomarker of neuroinflammation in Alzheimer's disease and other diseases of the central nervous system
ADDF-32 Menniti, Frank Alzheimer's Drug Discovery Foundation 2021
Evaluating the effects of GLP-1 analog, oral semaglutide, as a treatment for sporadic behavioral variant frontotemporal dementia (bvFTD)
ADDF-33 Edison, Paul Alzheimer's Drug Discovery Foundation 2021
Open-label Clinical Trial of Nabilone for Neuropsychiatric Symptoms in Frontotemporal Dementia
ADDF-34 Ducharme, Simon Alzheimer's Drug Discovery Foundation 2021